DAFNA Capital Management’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$639K Hold
93,812
0.15% 72
2025
Q4
$790K Buy
+93,812
New +$1.04M 0.18% 64
2025
Q3
Sell
-33,750
Closed -$329K 76
2025
Q2
$329K Sell
33,750
-3,750
-10% -$39.5K 0.09% 69
2025
Q1
$453K Hold
37,500
0.13% 73
2024
Q4
$577K Hold
37,500
0.15% 71
2024
Q3
$864K Hold
37,500
0.2% 64
2024
Q2
$726K Hold
37,500
0.17% 67
2024
Q1
$1.41M Buy
+37,500
New +$1.55M 0.32% 54
2023
Q4
Sell
-49,816
Closed -$1.09M 77
2023
Q3
$1.09M Hold
49,816
0.34% 54
2023
Q2
$1.94M Hold
49,816
0.53% 41
2023
Q1
$4.59M Buy
49,816
+10,344
+26% +$1.3M 1.38% 26
2022
Q4
$5.65M Sell
39,472
-19,013
-33% -$4.74M 1.59% 18
2022
Q3
$13.3M Hold
58,485
3.58% 7
2022
Q2
$13.7M Buy
58,485
+13,743
+31% +$3.02M 3.72% 4
2022
Q1
$14.3M Sell
44,742
-1,081
-2% -$249K 3.73% 5
2021
Q4
$12.8M Buy
45,823
+22,305
+95% +$3.83M 3.22% 4
2021
Q3
$2.95M Hold
23,518
0.78% 31
2021
Q2
$3.87M Sell
23,518
-549
-2% -$112K 0.81% 31
2021
Q1
$5.04M Buy
24,067
+19,218
+396% +$4.41M 1.2% 24
2020
Q4
$1.09M Buy
4,849
+625
+15% +$128K 0.32% 57
2020
Q3
$803K Buy
+4,224
New +$1.07M 0.26% 59

Other funds holding ACET